Polymorphisms of the lipoprotein lipase gene as genetic markers for stroke in colombian population: a case control study
Abstract
Objective:To analyze if there is an association between the presence of polymorphisms in the LPL gene (rs320, rs285 and rs328) with development of acute ischemic stroke in Colombian population.
Methods:In a case control design, 133 acute ischemic stroke patients (clinical diagnosis and x-ray CT) and 269 subjects without stroke as controls were studied. PCR -RFLP technique was used to detect rs320, rs285 and rs328 polymorphisms in the LPL gene.
Results:In the present research was not found any association between any of the LPL gene polymorphism and acute ischemic stroke in the population studied; the allele and genotypic frequencies of the studied polymorphisms were similar in cases and controls and followed the Hardy-Weinberg equilibrium. The study was approved by the IRB and each subject signed the informed consent.
Conclusion:LPL gene polymorphisms are not genetic markers for the development of stroke in the Colombian sample used.
Authors
Downloads
Keywords
- Coronary Disease
- Lipoprotein lipase
- Genotype
- Myocardial Infarction
- Polymorphism Genetic
- Lipoprotein Lipase
- Polymorphism Single Nucleotide
- Risk
- Colombia
References
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A. An updated definition of stroke for the 21st century a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089
Wong H, Davis RC, Thuren T, Goers JW, Nikazy J, Waite M. Lipoprotein lipase domain function. J Biol Chem. 1994;269(14):10319–10323
Chen Q, Razzaghi H, Demirci FY, Kamboh MI. Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease. Atherosclerosis. 2008;200(1):102–108
Wang H, Eckel RH. Lipoprotein lipase from gene to obesity. Am J Physiol Endocrinol Metab. 2009;297(2):E271–E288
Sepetiba RJ, Andrade J, Hirata RD, Hirata MH, Sepetiba CR, Nakamura Y. Lipoprotein lipase PvuII polymorphism is associated with variations in serum lipid levels in non-diabetic pregnant women. Brazil J Med Biol Res. 2007;40(7):919–926
Silva FA ZJ, Quintero C, Arenas W, Rueda-Clausen CF. Enfermedad cerebrovascular en Colombia. Rev Colomb Cardiol. 2006;13:85–89
Nicklas BJ, Ferrell RE, Rogus EM, Berman DM, Ryan AS, Dennis KE. Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women. Human Genetics. 2000;106(4):420–424
Gigek Cde O, Chen ES, Cendoroglo MS, Ramos LR, Araujo LM, Payao SL. Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels. Clin Chem Lab Med. 2007;45(5):599–604
Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM. Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin Chim Acta. 2000;300(1-2):139–149
Morabia A, Cayanis E, Constanza MC, Ross BM, Flaherty MS, Alvin GB, Das K, Morris MA. Association between lipoprotein lipase (LPL) gene and blood lipids: a common variant for a common trait? Genet Epidemiol. 2003;24:309–321
Mattu RK, Needham EW, Morgan R, Rees A, Hackshaw AK, Stocks J. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arteriosclerosis Thrombosis. 1994;14(7):1090–1097
Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. World Health Organization; Geneva: 2011
Kay A, März W, Hoffmann MM, Zhang Q, Masana L, Cavanna J. Coronary artery disease and dyslipidemia within Europe genetic variants in lipid transport gene loci in German subjects with premature coronary artery disease. Atheroscler Suppl. 2002;3(1):27–33
Jemaa R FF, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou JP, Bard JM, Fruchart JC. Lipoprotein lipase gene polymorphisms associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde. J Lipid Res. 1995;36(10):2141–2146
Shimo-Nakanishi Y, Urabe T, Hattori N, Watanabe Y, Nagao T, Yokochi M. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke. 2001;32(7):1481–1486
Xu E, Li W, Zhan L, Guan G, Wang X, Chen S. Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese. Neuroscience. 2008;155(2):403–408
Yin R, Wang Y, Chen G, Lin W, Yang D, Pan S. Lipoprotein lipase gene polymorphism at the PvuII locus and serum lipid levels in Guangxi Hei Yi Zhuang and Han populations. Clin Chem Lab Med. 2006;44(12):1416–1421
Stocks J, Thorn JA, Galton DJ. Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res. 1992;33(6):853–857
Rachel E. Peacock AH, Peter Nilsson-Ehle, Steve E Humphries Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis. 1992;97(2):171–185
Abu-Amero KK, Wyngaard CA, Al-Boudari OM, Kambouris M, Dzimiri N. Lack of association of lipoprotein lipase gene polymorphisms with coronary artery disease in the Saudi Arab population. Arch Path Lab Med. 2003;127(5):597–600
Kuivenhoven JA, Groenemeyer BE, Boer JM, Reymer PW, Berghuis R, Bruin T. Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler Thromb Vasc Biol. 1997;17(3):595–599
Fidani L, Hatzitolios AI, Goulas A, Savopoulos C, Basayannis C, Kotsis A. Cholesteryl ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients. Neurosci Lett. 2005;384(1-2):102–105
Munshi A, Babu MS, Kaul S, Rajeshwar K, Balakrishna N, Jyothy A. Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes. J Neurol Sci. 2012;318(1-2):51–54
Rebhi L, Kchok K, Omezzine A, Kacem S, Rejeb J, Ben Hadjmbarek I. Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population. Mol Biol Rep. 2012;39(11):9893–9901
Larson I, Hoffmann MM, Ordovas JM, Schaefer EJ, Marz W, Kreuzer J. The lipoprotein lipase HindIII polymorphism association with total cholesterol and LDL-cholesterol, but not with HDL and triglycerides in 342 females. Clin Chem. 1999;45(7):963–968
Parfenov MG, Nikolaeva TY, Sudomoina MA, Fedorova SA, Guekht AB, Gusev EI. Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity. J Neurol Sci. 2007;255(1-2):42–49
Gambino R SL, Alemanno N, Pagano G, Cassader M. Human Lipoprotein Lipase HindlII Polymorphism in Young Patients With Myocardial Infarction. Metabolism. 1999;48(9):1157–1161
Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J. Association of lipoprotein lipase gene polymorphisms with coronary artery disease. J Am Coll Cardiol. 1999;33(4):1013–1020
Wang XL, McCredie RM, Wilcken DE. Common DNA polymorphisms at the lipoprotein lipase gene Association with severity of coronary artery disease and diabetes. Circulation. 1996;93(7):1339–1345
Georgiev A, Panov S, Sadikario S. Association of PvuII polymorphism in the lipoprotein lipase gene with the coronary artery disease in Macedonian population. Prilozi. 2008;29(2):213–225
Copyright (c) 2016 Universidad del Valle
This work is licensed under a Creative Commons Attribution 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
